Market Value903,799,594
Total Holdings51
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
JBIO / Jade Biosciences, Inc.
ACRS / Aclaris Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc. Call
KROS / Keros Therapeutics, Inc.
UNCY / Unicycive Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
RYTM / Rhythm Pharmaceuticals, Inc.
BCAX / Bicara Therapeutics Inc.
CLDX / Celldex Therapeutics, Inc.
BHVN / Biohaven Ltd.
RNA / Avidity Biosciences, Inc.
BIIB / Biogen Inc.
ARTV / Artiva Biotherapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
UNCY / Unicycive Therapeutics, Inc.
ETNB / 89bio, Inc.
AVTE / Aerovate Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
ALLK / Allakos Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
GERN / Geron Corporation
GLYC / GlycoMimetics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
XNCR / Xencor, Inc.
RAPP / Rapport Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
ANNX / Annexon, Inc.
JAZZ / Jazz Pharmaceuticals plc
PRAX / Praxis Precision Medicines, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
IRON / Disc Medicine, Inc.
ERAS / Erasca, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
TRVI / Trevi Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
SEPN / Septerna, Inc.
ELVN / Enliven Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
MAZE / Maze Therapeutics, Inc.
IMVT / Immunovant, Inc.
DSGN / Design Therapeutics, Inc.
OCUL / Ocular Therapeutix, Inc.
MLTX / MoonLake Immunotherapeutics
IDYA / IDEAYA Biosciences, Inc.
VSTM / Verastem, Inc.
CDTX / Cidara Therapeutics, Inc.
ARVN / Arvinas, Inc.
ARVN / Arvinas, Inc. Call
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
KRYS / Krystal Biotech, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Call
JANX / Janux Therapeutics, Inc.
JANX / Janux Therapeutics, Inc. Call
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
MTSR / Metsera, Inc.
UTHR / United Therapeutics Corporation
OLMA / Olema Pharmaceuticals, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
CBIO / Crescent Biopharma, Inc.